The forecasted import value of penicillins to Canada shows a declining trend from 2024 to 2028, starting at $10.124 million in 2024 and decreasing steadily to $3.4488 million by 2028. This represents a year-on-year decline with an average annual decrease projected by the CAGR over this five-year period. As of 2023, the actual value stood higher than projected 2024 figures, indicating an anticipated downturn in imports possibly due to reduced demand or increased local production.
Future trends to watch for include the impacts of potential pharmaceutical advances, policy changes relating to drug imports, and shifts in global supply chains which could influence the Canadian market for penicillins. Monitoring these factors will be crucial for strategic planning in the sector.
